{"url_path":"/sec/irmd/8-k/2026-06-24/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1325618/0001628280-26-045059-index.html","accession_number":"0001628280-26-045059","cik":"0001325618","ticker":"IRMD","issuer_name":"IRADIMED CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1325618/0001628280-26-045059-index.html","primary_entity_key":"0001325618","primary_entity_name":"IRADIMED CORP"},"word_count":218,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nThe Annual Meeting of Stockholders of Iradimed Corporation (“Iradimed”) was held on Tuesday, June 23, 2026. At the meeting, Iradimed’s stockholders voted on the following three proposals and cast their votes as described below.\n\n1.Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed’s Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director’s successor shall have been duly elected and qualified (or, if earlier, such director’s removal or resignation from our Board), as set forth below.\n\nNameVotes ForVotes WithheldBroker Non-Votes\n\nRoger Susi8,638,1781,972,758759,594\n\nMonty Allen9,266,5491,344,387759,594\n\nJoe Kiani10,492,206118,730759,594\n\nHilda Scharen-Guivel10,409,481201,455759,594\n\nJames Hawkins8,244,8022,366,134759,594\n\n2.Stockholders ratified the selection of RSM US LLP as Iradimed’s independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth below.\n\nVotes ForVotes AgainstAbstentions\n\n11,355,8918,7165,923\n\n3.Stockholders approved an advisory resolution on the compensation of Iradimed’s named executive officers.\n\nVotes ForVotes AgainstAbstentionsBroker Non-Votes\n\n10,487,387106,03017,519759,594\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nIRADIMED CORPORATION\n\nDate: June 24, 2026\n\nBy: /s/John Glenn\n\nName: John Glenn\n\nTitle: Chief Financial Officer"}